Open AccessPrognostic value of the monoethylglycinexylidide test in alcoholic cirrhosis
Author(s) -
Satish B Bhise,
Remeth J. Dias,
Kailas K. Mali
Publication year - 2007
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/1319-3767.33462
Subject(s) - medicine , cirrhosis , receiver operating characteristic , gastroenterology , cutoff , alcoholic liver disease , liver function tests , liver disease , stage (stratigraphy) , survival analysis , discriminant function analysis , liver function , paleontology , physics , quantum mechanics , machine learning , computer science , biology
The existing conventional liver function tests (LFTs) are indirect, inferior and have limited prognostic value. Therefore, the monoethylglycinexylidide (MEGX) test, which provides a direct measure of the actual functional state of the liver, is proposed as a real-time liver function test. The objective of this study was to assess the prognostic value of the MEGX test in cirrhosis by comparing it with Child-Turcotte-Pugh (CTP), the Mayo end stage liver disease (MELD) and discriminant function (DF) scores.